We are live on ! Find out more
IFRX icon

InflaRx
IFRX

28 hedge funds and large institutions have $15.3M invested in InflaRx in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.39% more ownership

Funds ownership: 13.41% → 13.8% (+0.39%)

5% less capital invested

Capital invested by funds: $16.1M → $15.3M (-$790K)

20% less funds holding

Funds holding: 35 → 28 (-7)

54% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 13

60% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 10

Holders
28
Holders Change
-7
Holders Change %
-20%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
13
Closed
10
Calls
$358K
Puts
–
Net Calls
+$358K
Net Calls Change
+$697K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.1M
2
SSA
Schonfeld Strategic Advisors
New York
+$798K
3
FIA
FNY Investment Advisers
New York
+$645K
4
RJA
Raymond James & Associates
Florida
+$212K
5
Squarepoint
Squarepoint
New York
+$157K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$676K
2
Two Sigma Investments
Two Sigma Investments
New York
-$306K
3
BBA
Baker Bros. Advisors
New York
-$235K
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$227K
5
GCP
GSA Capital Partners
United Kingdom
-$157K
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$4.29M -$235K -50,996 -5%
O
2
OrbiMed
New York
$2.89M – – –
Morgan Stanley
3
Morgan Stanley
New York
$2.61M +$1.1M +238,838 +64%
FIA
4
FNY Investment Advisers
New York
$1.49M +$645K +140,000 +67%
SSA
5
Schonfeld Strategic Advisors
New York
$889K +$798K +173,361 +492%
IC
6
Ikarian Capital
Texas
$637K -$13.1K -2,850 -2%
Goldman Sachs
7
Goldman Sachs
New York
$459K -$18.2K -3,949 -4%
Verition Fund Management
8
Verition Fund Management
Connecticut
$383K -$23K -5,000 -5%
BC
9
Birchview Capital
Vermont
$298K – – –
SFI
10
Susquehanna Fundamental Investments
Pennsylvania
$216K +$111K +24,000 +90%
RJFSA
11
Raymond James Financial Services Advisors
Florida
$204K -$42.8K -9,290 -16%
RJA
12
Raymond James & Associates
Florida
$196K +$212K +46,090 New
Two Sigma Advisers
13
Two Sigma Advisers
New York
$187K -$82.4K -17,900 -29%
Squarepoint
14
Squarepoint
New York
$145K +$157K +34,045 New
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$133K -$128K -27,776 -47%
BFM
16
Boothbay Fund Management
New York
$106K -$2.19K -475 -2%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$61K -$81K -17,588 -55%
BlackRock
18
BlackRock
New York
$23K – – –
Rockefeller Capital Management
19
Rockefeller Capital Management
New York
$21K – – –
AA
20
AlphaCentric Advisors
Puerto Rico
$13K +$13.8K +3,000 New
TRCT
21
Tower Research Capital (TRC)
New York
$9K -$571 -124 -6%
UBS Group
22
UBS Group
Switzerland
$8K +$2.28K +496 +36%
SPIA
23
Steward Partners Investment Advisory
New York
$6K -$921 -200 -13%
Renaissance Technologies
24
Renaissance Technologies
New York
– -$676K -147,373 Closed
Two Sigma Investments
25
Two Sigma Investments
New York
– -$306K -66,636 Closed
1
2

IFRX Hedge Fund Activity: Q3 2020 in Review

28 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q3 2020, worth a combined $15.3M — down 4.9% from $16.1M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of IFRX and 4 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 6 added.

The largest buyer was Morgan Stanley, adding an estimated $1.1M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $676K sold.

  • 28 institutional investors held InflaRx (IFRX) as of Q3 2020, down from 35 in Q2 2020.
  • Funds reported $15.3M of InflaRx stock for Q3 2020, down 4.9% quarter-over-quarter.
  • 4 funds opened new InflaRx positions in Q3 2020 and 10 closed out, a net change of -6 holders.
  • The largest InflaRx buyer in Q3 2020 was Morgan Stanley, an estimated $1.1M added.
  • The largest InflaRx seller in Q3 2020 was Renaissance Technologies, an estimated $676K sold.

Based on aggregated 13F filings for Q3 2020.